{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T04:44:39Z","timestamp":1768711479330,"version":"3.49.0"},"reference-count":73,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T00:00:00Z","timestamp":1727222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Peanut allergy, one of the most frequently occurring allergies, usually starts in childhood and rarely subsides\u2014often persisting throughout adult life. Accidental exposure to peanuts can often result in adverse reactions ranging from mild to life-threatening, such as anaphylactic shock. Historically, food avoidance and the use of rescue drugs have remained a fundamental management mechanism for dealing with food allergy. However, prevention of adverse reactions to food allergy is playing an increasing role. This is possible through the early introduction of peanuts into the diet, especially in infants at risk of this allergy. In recent years, specific immunotherapy has been used to develop desensitisation and, in some patients, tolerance\u2014defined as a persistent state of clinical non-reactivity to the allergen after therapy is finished. The aim of this article is to summarise the current state of knowledge on the prevention and treatment of peanut allergy, with a focus on clinical trials, current guidelines, and recent experimental studies. This review may be particularly useful for paediatricians and general practitioners.<\/jats:p>","DOI":"10.3390\/nu16193237","type":"journal-article","created":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T04:01:24Z","timestamp":1727236884000},"page":"3237","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Peanut Allergy in Children\u2014Is Prevention Better than Cure?"],"prefix":"10.3390","volume":"16","author":[{"given":"Alicja","family":"Krejner-Bienias","sequence":"first","affiliation":[{"name":"Department of Pediatric Pneumonology and Allergy, Medical University of Warsaw, 02-091 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2226-3509","authenticated-orcid":false,"given":"Klementyna","family":"\u0141y\u017cwa","sequence":"additional","affiliation":[{"name":"Department of Pediatric Pneumonology and Allergy, Medical University of Warsaw, 02-091 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Krupa-\u0141aska","sequence":"additional","affiliation":[{"name":"Department of Pediatric Pneumonology and Allergy, Medical University of Warsaw, 02-091 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Zieli\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Pediatric Pneumonology and Allergy, Medical University of Warsaw, 02-091 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marek","family":"Kulus","sequence":"additional","affiliation":[{"name":"Department of Pediatric Pneumonology and Allergy, Medical University of Warsaw, 02-091 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2876-104X","authenticated-orcid":false,"given":"Katarzyna","family":"Grzela","sequence":"additional","affiliation":[{"name":"Department of Pediatric Pneumonology and Allergy, Medical University of Warsaw, 02-091 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,9,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1016\/j.jaip.2020.04.020","article-title":"Prevalence of Food Sensitization and Food Allergy in Children Across Europe","volume":"8","author":"Lyons","year":"2020","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nri3632","article-title":"The production and regulation of IgE by the immune system","volume":"14","author":"Wu","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1111\/all.14747","article-title":"Basophil activation test: Mechanisms and considerations for use in clinical trials and clinical practice","volume":"76","author":"Santos","year":"2021","journal-title":"Allergy"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"100557","DOI":"10.1016\/j.waojou.2021.100557","article-title":"Erratum to \u201cIgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper\u201d [World Allergy Organ J 13\/2 (2020) 100080]","volume":"14","author":"Ansotegui","year":"2021","journal-title":"World Allergy Organ. J."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1111\/all.12429","article-title":"EAACI food allergy and anaphylaxis guidelines: Diagnosis and management of food allergy","volume":"69","author":"Muraro","year":"2014","journal-title":"Allergy"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e185630","DOI":"10.1001\/jamanetworkopen.2018.5630","article-title":"Prevalence and Severity of Food Allergies Among US Adults","volume":"2","author":"Gupta","year":"2019","journal-title":"JAMA Netw. Open"},{"key":"ref_7","first-page":"544","article-title":"Tree nut allergy","volume":"38","author":"Kuzminski","year":"2021","journal-title":"Postep. Dermatol. Alergol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.jaci.2015.01.002","article-title":"Natural history of peanut allergy and predictors of resolution in the first 4 years of life: A population-based assessment","volume":"135","author":"Peters","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/pai.12563","article-title":"EAACI Molecular Allergology User\u2019s Guide","volume":"27","author":"Matricardi","year":"2016","journal-title":"Pediatr. Allergy Immunol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1111\/imj.14658","article-title":"Current perspectives on peanut allergy","volume":"49","author":"Frith","year":"2019","journal-title":"Intern. Med. J."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/all.15032","article-title":"EAACI guidelines: Anaphylaxis (2021 update)","volume":"77","author":"Muraro","year":"2022","journal-title":"Allergy"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12948-016-0041-4","article-title":"Quality of life in patients with food allergy","volume":"14","author":"Manso","year":"2016","journal-title":"Clin. Mol. Allergy"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1056\/NEJMoa1414850","article-title":"Randomized trial of peanut consumption in infants at risk for peanut allergy","volume":"372","author":"Roberts","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/all.13319","article-title":"EAACI Guidelines on allergen immunotherapy: IgE-mediated food allergy","volume":"73","author":"Pajno","year":"2018","journal-title":"Allergy"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13601-015-0055-x","article-title":"Accidental exposures to peanut in a large cohort of Canadian children with peanut allergy","volume":"5","author":"Cherkaoui","year":"2015","journal-title":"Clin. Transl. Allergy"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jaci.2006.04.024","article-title":"Accidental ingestions in children with peanut allergy","volume":"118","author":"Yu","year":"2006","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jaip.2016.09.020","article-title":"Food Allergen Labeling and Purchasing Habits in the United States and Canada","volume":"5","author":"Marchisotto","year":"2017","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s12016-023-08960-6","article-title":"Food Allergy Labeling Laws: International Guidelines for Residents and Travelers","volume":"65","author":"Chang","year":"2023","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1007\/s00103-016-2361-4","article-title":"[Food allergen regulations in the EU]","volume":"59","author":"Demmel","year":"2016","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1111\/all.15167","article-title":"Proposal of 0.5 mg of protein\/100 g of processed food as threshold for voluntary declaration of food allergen traces in processed food-A first step in an initiative to better inform patients and avoid fatal allergic reactions: A GA\u00b2LEN position paper","volume":"77","author":"Zuberbier","year":"2022","journal-title":"Allergy"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1111\/cea.13479","article-title":"Understanding how con sumers with food allergies make decisions based on precautionary labelling","volume":"49","author":"DunnGalvin","year":"2019","journal-title":"Clin. Exp. Allergy"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"70","DOI":"10.5740\/jaoacint.17-0391","article-title":"Challenges and Path Forward on Mandatory Allergen Labeling and Voluntary Precautionary Allergen Labeling for a Global Company","volume":"101","author":"Yeung","year":"2018","journal-title":"J. AOAC Int."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S1081-1206(10)60908-8","article-title":"The impact of food allergy on the daily activities of children and their families","volume":"96","author":"Bollinger","year":"2006","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/jpc.13570","article-title":"Bullying and quality of life in children and adolescents with food allergy","volume":"53","author":"Fong","year":"2017","journal-title":"J. Paediatr. Child Health"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1399-3038.2012.01310.x","article-title":"Parent perceived quality of life is age-dependent in children with food allergy","volume":"23","author":"Wassenberg","year":"2012","journal-title":"Pediatr. Allergy Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/pai.13273","article-title":"Preventing food allergy in infancy and childhood: Systematic review of randomised controlled trials","volume":"31","author":"Halken","year":"2020","journal-title":"Pediatr. Allergy Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1542\/peds.111.S3.1662","article-title":"Food allergen avoidance in the prevention of food allergy in infants and children","volume":"111","author":"Zeiger","year":"2003","journal-title":"Pediatrics"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"American Academy of Pediatrics, and Committee on Nutrition (2000). Hypoallergenic infant formulas. Pediatrics, 106, 346\u2013349.","DOI":"10.1542\/peds.106.2.346"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1056\/NEJMoa1514210","article-title":"Randomized Trial of Introduction of Allergenic Foods in Breast-Fed Infants","volume":"374","author":"Perkin","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"5364","DOI":"10.3390\/ijerph10115364","article-title":"The impact of family history of allergy on risk of food allergy: A population-based study of infants","volume":"10","author":"Koplin","year":"2013","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.jaci.2011.01.031","article-title":"Loss-of-function variants in the filaggrin gene are a significant risk factor for peanut allergy","volume":"127","author":"Brown","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/cea.12406","article-title":"Which infants with eczema are at risk of food allergy? Results from a population-based cohort","volume":"45","author":"Martin","year":"2015","journal-title":"Clin. Exp. Allergy"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.jaci.2016.04.011","article-title":"Understanding the feasibility and implications of implementing early peanut introduction for prevention of peanut allergy","volume":"138","author":"Koplin","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e2010511","DOI":"10.1001\/jamanetworkopen.2020.10511","article-title":"Assessment of Pediatrician Awareness and Implementation of the Addendum Guidelines for the Prevention of Peanut Allergy in the United States","volume":"3","author":"Gupta","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1001\/jama.2016.12623","article-title":"Timing of Allergenic Food Introduction to the Infant Diet and Risk of Allergic or Autoimmune Disease: A Systematic Review and Meta-analysis","volume":"316","author":"Ierodiakonou","year":"2016","journal-title":"JAMA"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.jaci.2012.02.036","article-title":"Update on risk factors for food allergy","volume":"129","author":"Lack","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_37","unstructured":"British Society for Allergy & Clinical Immunology and British Dietetic Association (2024, May 05). Preventing Food Allergy in Higher Risk Infants: Guidance for Healthcare Professionals. Available online: https:\/\/www.bsaci.org\/professional-resources\/resources\/early-feeding-guidelines\/."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/pai.13496","article-title":"EAACI guideline: Preventing the development of food allergy in infants and young children (2020 update)","volume":"32","author":"Halken","year":"2021","journal-title":"Pediatr. Allergy Immunol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jaip.2020.11.002","article-title":"A Consensus Approach to the Primary Prevention of Food Allergy through Nutrition: Guidance from the American Academy of Allergy, Asthma, and Immunology; American College of Allergy, Asthma, and Immunology; and the Canadian Society for Allergy and Clinical Immunology","volume":"9","author":"Fleischer","year":"2021","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/jama.2022.9224","article-title":"Association Between Earlier Introduction of Peanut and Prevalence of Peanut Allergy in Infants in Australia","volume":"328","author":"Soriano","year":"2022","journal-title":"JAMA"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"89","DOI":"10.5694\/mja2.12102","article-title":"The Australasian Society of Clinical Immunology and Allergy infant feeding for allergy prevention guidelines","volume":"210","author":"Joshi","year":"2019","journal-title":"Med. J. Aust."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jaci.2016.10.010","article-title":"Addendum guidelines for the prevention of peanut allergy in the United States: Report of the National Institute of Allergy and Infectious Diseases-sponsored expert panel","volume":"139","author":"Togias","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_43","unstructured":"(2022, April 27). Dietary Exposures and Allergy Prevention in High-Risk Infants|Canadian Paediatric Society. Available online: https:\/\/cps.ca\/documents\/position\/dietary-exposures-and-allergy-prevention."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1111\/all.13446","article-title":"\u201cTo screen or not to screen\u201d: Comparing the health and economic benefits of early peanut introduction strategies in five countries","volume":"73","author":"Shaker","year":"2018","journal-title":"Allergy"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.anai.2018.03.001","article-title":"Caregiver and expecting caregiver support for early peanut introduction guidelines","volume":"120","author":"Greenhawt","year":"2018","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.jaci.2019.07.032","article-title":"Earlier ingestion of peanut after changes to infant feeding guidelines: The EarlyNuts study","volume":"144","author":"Soriano","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"PALISADE Group of Clinical Investigators (2018). AR101 Oral Immunotherapy for Peanut Allergy. N. Engl. J. Med., 37, 1991\u20132001.","DOI":"10.1056\/NEJMoa1812856"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0140-6736(21)02390-4","article-title":"Efficacy and safety of oral immunotherapy in children aged 1\u20133 years with peanut allergy (the Immune Tolerance Network IMPACT trial): A randomised placebo-controlled study","volume":"399","author":"Jones","year":"2022","journal-title":"Lancet"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/j.jaip.2022.05.040","article-title":"The Case for Prompt Salvage Infant Peanut Oral Immunotherapy Following Failed Primary Prevention","volume":"10","author":"Chua","year":"2022","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1056\/NEJMoa2212895","article-title":"Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut Allergy","volume":"388","author":"Greenhawt","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_51","first-page":"e21832","article-title":"Immunotherapy Effectiveness in Treating Peanut Hypersensitivity: A Systemic Review","volume":"14","author":"Alghamdi","year":"2022","journal-title":"Cureus"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.anai.2020.03.028","article-title":"Quality of life improves significantly after real-world oral immunotherapy for children with peanut allergy","volume":"125","author":"Blackman","year":"2020","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jaip.2018.06.016","article-title":"Quality of Life of Food-Allergic Patients before, during, and after Oral Immunotherapy","volume":"7","author":"Goldberg","year":"2019","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.anai.2019.02.006","article-title":"Food oral immunotherapy is superior to food avoidance-CON","volume":"122","author":"Braun","year":"2019","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jaci.2016.05.027","article-title":"Early oral immunotherapy in peanut-allergic preschool children is safe and highly effective","volume":"139","author":"Vickery","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1016\/j.jaip.2020.03.016","article-title":"Community Private Practice Clinical Experience with Peanut Oral Immunotherapy","volume":"8","author":"Afinogenova","year":"2020","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Grzeskowiak, L.E., Tao, B., Knight, E., Cohen-Woods, S., and Chataway, T. (2020). Adverse events associated with peanut oral immunotherapy in children\u2014A systematic review and meta-analysis. Sci. Rep., 10.","DOI":"10.1038\/s41598-019-56961-3"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.jaci.2016.08.010","article-title":"Omalizumab facilitates rapid oral desensitization for peanut allergy","volume":"139","author":"MacGinnitie","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1111\/cea.13469","article-title":"Individually dosed omalizumab facilitates peanut oral immunotherapy in peanut allergic adolescents","volume":"49","author":"Brandstrom","year":"2019","journal-title":"Clin. Exp. Allergy"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1056\/NEJMoa2312382","article-title":"Omalizumab for the Treatment of Multiple Food Allergies","volume":"390","author":"Wood","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jaci.2020.08.039","article-title":"Determinants of omalizumab dose-related efficacy in oral immunotherapy: Evidence from a cohort of 181 patients","volume":"147","author":"Azzano","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"100690","DOI":"10.1016\/j.waojou.2022.100690","article-title":"The rationale for development of ligelizumab in food allergy","volume":"15","author":"Wood","year":"2022","journal-title":"World Allergy Organ. J."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1111\/cea.12400","article-title":"Pharmacokinetics, pharmacodynamics and safety of QGE031 (ligelizumab), a novel high-affinity anti-IgE antibody, in atopic subjects","volume":"44","author":"Arm","year":"2014","journal-title":"Clin. Exp. Allergy"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/s41467-019-13815-w","article-title":"The mechanistic and functional profile of the therapeutic anti-IgE antibody ligelizumab differs from omalizumab","volume":"11","author":"Gasser","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1146\/annurev-immunol-090122-043501","article-title":"The Immunobiology and Treatment of Food Allergy","volume":"42","author":"Barshow","year":"2024","journal-title":"Annu. Rev. Immunol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/S0140-6736(19)30420-9","article-title":"Oral immunotherapy for peanut allergy (PACE): A systematic review and meta-analysis of efficacy and safety","volume":"393","author":"Chu","year":"2019","journal-title":"Lancet"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13223-021-00533-6","article-title":"Practical challenges in oral immunotherapy resolved through patient-centered care","volume":"17","author":"Graham","year":"2021","journal-title":"Allergy Asthma Clin. Immunol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"100010","DOI":"10.1016\/j.waojou.2018.11.008","article-title":"The safety of oral immunotherapy for food allergy during maintenance phase: Effect of counselling on adverse reactions","volume":"12","author":"Arasi","year":"2019","journal-title":"World Allergy Organ. J."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.jaci.2016.07.030","article-title":"Novel baseline predictors of adverse events during oral immunotherapy in children with peanut allergy","volume":"139","author":"Virkud","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/j.jaip.2023.02.032","article-title":"Evening ingestion as a potential reaction cofactor during peanut oral immunotherapy in children","volume":"11","author":"Morris","year":"2023","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Lazizi, S., Labrosse, R., and Graham, F. (2022). Transitioning peanut oral immunotherapy to clinical practice. Front. Allergy, 3.","DOI":"10.3389\/falgy.2022.974250"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/ACI.0000000000000688","article-title":"Eosinophilic esophagitis as a complication of food oral immunotherapy","volume":"20","author":"Jin","year":"2020","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/ACI.0000000000000537","article-title":"Eosinophilic esophagitis during sublingual and oral allergen immunotherapy","volume":"19","author":"Cafone","year":"2019","journal-title":"Curr. Opin. Allergy Clin. Immunol."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/16\/19\/3237\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:02:09Z","timestamp":1760112129000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/16\/19\/3237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,25]]},"references-count":73,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["nu16193237"],"URL":"https:\/\/doi.org\/10.3390\/nu16193237","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,25]]}}}